By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Lentigen Corporation 

1450 South Rolling Road

Baltimore  Maryland  21227  U.S.A.
Phone: 443-543-5300 Fax: 443-543-5301


Key Statistics

Ownership: Private

Web Site: Lentigen Corporation


Company News
Lentigen Corporation Appoints Lentigen Technology, Inc. To Manufacture The Lentiviral Vector For Its First CAR-Treg Program In Transplant Rejection 6/20/2017 11:22:45 AM
Lentigen Corporation Announces Sale Of Lentiviral Vector Manufacturing Business And Change Of Name To Opus Bio, Inc. 8/15/2014 8:21:41 AM
Miltenyi Biotec, Inc. Acquires Gene Therapy Assets From Lentigen Corporation 8/14/2014 1:27:56 PM
Lentigen Corporation Receives U.S. Orphan Drug Designation for Novel Gene Therapy for Glioblastoma Multiforme 2/14/2013 8:33:25 AM
Lentigen Corporation and UH Case Medical Center Initiate Phase I Trial Using Gene Therapy and Bone Marrow Stem Cells in the Treatment of Brain Cancer 11/14/2011 2:04:50 PM
Lentigen Corporation Awarded $1.2 Million by U.S. Government Under the Qualifying Therapeutic Discovery Project 11/4/2010 6:52:33 AM
Lentigen Corporation Awarded Phase II SBIR Grant for Clinical Development of TCR Immunotherapy Targeted to Melanoma 8/9/2010 9:28:15 AM
Lentigen Corporation Awarded Phase I STTR Grant for Hunter Syndrome 5/18/2010 9:54:53 AM
International AIDS Vaccine Initiative and Lentigen Corporation to Collaborate on Design of Novel AIDS Vaccine Candidate 4/22/2010 11:11:20 AM
Lentigen Corporation Awarded Phase I SBIR Grant for Hepatitis C Vaccine 12/9/2009 10:02:33 AM